ICP
BIIB icon

Interchange Capital Partners’s Biogen BIIB Stock Holding History

Interchange Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,024
Closed -$495K – 114
2021
Q1 		$495K Buy
1,024
+95
+10% +$25.6K 0.27% 121
2020
Q4 		$227K Buy
+929
New +$240K 0.12% 191

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Interchange Capital Partners's BIIB Position: Q2 2021 in Review

Interchange Capital Partners sold out of Biogen (BIIB) in Q2 2021, closing a stake of 1,024 shares — an estimated $495K sold.

Interchange Capital Partners first reported a position in BIIB in Q4 2020 and held it in 2 quarters. The position peaked at $495K in Q1 2021. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Interchange Capital Partners reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 1,024 Biogen shares in Q2 2021, an estimated $495K.
  • Interchange Capital Partners first reported a position in Biogen in Q4 2020 and held it in 2 quarters.
  • Interchange Capital Partners's Biogen position peaked at $495K in Q1 2021.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Interchange Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.